Zhang Hao-Li HL

Show results for

Unknown (39)
Metabolomics (2)
Genomics (1)
Transcriptomics (1)

Organisms

Mus musculus (2)

Repository

biostudies-arrayexpress (2)
MetaboLights (2)

Technology Type

Mass spectrometry (2)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2015 (1)
2013 (1)
2023 (1)
2021 (1)

CHEBI ID

CHEBI:10037 (1)
CHEBI:10072 (1)
CHEBI:1015 (1)
CHEBI:10276 (1)
CHEBI:107646 (1)
CHEBI:108592 (1)
CHEBI:108595 (1)
CHEBI:109547 (1)
CHEBI:109895 (1)
CHEBI:110163 (1)
CHEBI:114185 (1)
CHEBI:114196 (1)
CHEBI:116314 (1)
CHEBI:122 (1)
CHEBI:125539 (1)
CHEBI:12962 (1)
CHEBI:131762 (1)
CHEBI:131914 (1)
CHEBI:13248 (1)
CHEBI:132629 (1)
CHEBI:132639 (1)
CHEBI:132823 (1)
CHEBI:132958 (1)
CHEBI:133086 (1)
CHEBI:13332 (1)
CHEBI:133542 (1)
CHEBI:134355 (1)
CHEBI:135010 (1)
CHEBI:135679 (1)
CHEBI:141315 (1)

Metabolite Name

(+-)-Baclofen (1)
(3E)-3-Benzylidene-4-Methyl-1H-1,4-Benzodiazepine-2,5-Dione (1)
(5R)-5-Hydroxy-1-(4-Hydroxy-3-Methoxyphenyl)Tetradecan-3-One (1)
(R)-3-Hydroxybutanoate (1)
1,2,4-triazines (1)
1,2-Dihydroxyheptadec-16-En-4-Yl Acetate (1)
1,3-Dideacetyl-7-Deacetoxy-7-Oxokhivorin (1)
1,4-Cyclohexanedicarboxylic Acid (1)
1,4-benzodiazepines (1)
1,8,9-Anthracenetriol (1)
1-Hydroxy-2-Naphthoic Acid (1)
1-Hydroxyanthraquinone (1)
1-benzopyrans (1)
1-hydroxy-2-unsubstituted benzenoids (1)
1-hydroxy-4-unsubstituted benzenoids (1)
16-Hydroxypalmitate (1)
2,4-Dihydroxybenzophenone (1)
2,4-Dinitrophenol (1)
2,5-Dihydroxy-3-Undecylcyclohexa-2,5-Diene-1,4-Dione (1)
2,6-dimethyl-3-benzazocines (1)
2-Hydroxybenzaldehyde (1)
2-Hydroxyisocaproic Acid (1)
2-Naphthalene Sulfonic Acid (1)
2-Oxoglutarate (1)
2-arylbenzofuran flavonoids (1)
2-benzimidazolylcarbamic acid esters (1)
2-benzopyrans (1)
3,4,5-Trimethoxycinnamic Acid (1)
3,4-dihydrocoumarins (1)
3-(4-Hydroxyphenyl)lactate (1)

Study type

Methylation profiling by high throughput sequencing (1)
RNA-seq of coding RNA (1)

Release Date

2017 (9)
2024 (4)
2022 (4)
2018 (4)
2025 (3)
2020 (3)
2019 (3)
2015 (2)
2013 (2)
2023 (2)
2021 (2)
2016 (2)
2014 (1)

Previous page
1 / 5
You're on page 1
page 2
page 3
page 4
page 5
Next page

Sort by:

Relevance

Page size

Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study.

Not available

S-EPMC6805485 | biostudies-literature

Genome-wide analysis reveals TET- and TDG-mediated 5-methylcytosine oxidation dynamics [MeDIP-Seq]

Ten-eleven translocation (Tet) family of DNA dioxygenases converts 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5- carboxylcytosine (5caC) through iterative oxidation reactions. While 5mC and 5hmC are relatively abundant, 5fC and 5caC are at very low levels...

ORGANISM(S): Mus musculus

2013-04-18 | E-GEOD-46111 | biostudies-arrayexpress

Genetic screening for hearing loss of 38,589 neonates with follow-up in South China.

Not available

S-EPMC12801692 | biostudies-literature

m6A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency

N6-methyladenosine (m6A) has been recently identified as a conserved epitranscriptomic modification of eukaryotic mRNAs, but its features, regulatory mechanisms, and functions in cell reprogramming are largely unknown. Here, we report m6A modification profiles in the mRNA transcriptomes of four cell...

ORGANISM(S): Mus musculus

2015-03-10 | E-GEOD-52125 | biostudies-arrayexpress

Two novel diterpenoid heterodimers, Bisebracteolasins A and B, from Euphorbia ebracteolata Hayata, and the cancer chemotherapeutic potential of Bisebracteolasin A.

Not available

S-EPMC5674023 | biostudies-literature

GRADE Use in Evidence Syntheses Published in High-Impact-Factor Gynecology and Obstetrics Journals: A Methodological Survey.

Not available

S-EPMC9866985 | biostudies-literature

Zinc mediates the SREBP-SCD axis to regulate lipid metabolism in Caenorhabditis elegans.

Not available

S-EPMC5580898 | biostudies-literature

Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.